People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study

Real-world data on Novo's Wegovy pill shows patients switching from obesity injections continued losing weight, suggesting weekly injections may not be necessary indefinitely. The findings indicate more convenient oral treatments could sustain weight loss, potentially expanding treatment options for patients and easing long-term adherence challenges in obesity care.